A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri; Wolfram Ruf; Jeffrey Weitz; Sam Schulman; Guy A. Young; Bianca Rocca; Emma C. Hansson; Milan Milojevic; Anders Jeppsson

doi:10.4081/btvb.2025.188

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Distal deep vein thrombosis: is there a way out of this dark forest?

Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

04-09-2024

https://doi.org/10.4081/btvb.2024.129

778

PDF: 255
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

27-07-2022

https://doi.org/10.4081/btvb.2022.34

4651

PDF: 397

Supplementary Files: 124
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1091

PDF: 351

APPENDIX: 70
Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

Mosaad Almegren

12-10-2023

https://doi.org/10.4081/btvb.2023.85

369

PDF: 158
Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

14-07-2022

https://doi.org/10.4081/btvb.2022.36

1058

PDF: 230
The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective

Augusto Di Castelnuovo

01-07-2025

https://doi.org/10.4081/btvb.2025.184

312

PDF: 103
Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

03-11-2022

https://doi.org/10.4081/btvb.2022.42

893

PDF: 291
The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action

Martina Berteotti, Walter Ageno, Rossella Marcucci, Andrea Stella, Paolo Zamboni, Romeo Martini

30-06-2025

https://doi.org/10.4081/btvb.2025.164

271

PDF: 90
Ankle brachial index for the diagnosis of asymptomatic lower extremity peripheral arterial disease

Francesco Cicconi

05-07-2024

https://doi.org/10.4081/btvb.2024.128

1343

PDF: 373
Stroke in women: anticoagulation in a complicated puzzle

Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

26-08-2024

https://doi.org/10.4081/btvb.2024.137

1112

PDF: 292
The subtle red line between combating and resolving inflammation in the cardiovascular disease, a “silent sniper”

Ciarán Kennedy, Luke J. Conroy, Braden Millar, Monica de Gaetano

30-06-2025

https://doi.org/10.4081/btvb.2025.187

279

PDF: 103
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

Mehrie H. Patel, Alok A. Khorana

16-05-2024

https://doi.org/10.4081/btvb.2024.113

559

PDF: 317
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Agnes Y.Y. Lee

29-02-2024

https://doi.org/10.4081/btvb.2024.111

1505

PDF: 387
The new era of anticoagulation: factor XI and XII inhibitors

Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

07-06-2023

https://doi.org/10.4081/btvb.2023.76

2201

PDF: 874
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Anna Falanga, Hugo Ten Cate, Bianca Rocca

27-01-2023

https://doi.org/10.4081/btvb.2023.60

692

PDF: 310
Unveiling the “common soil” of cardiovascular disease and cancer

Licia Iacoviello, Maria Benedetta Donati

24-02-2025

https://doi.org/10.4081/btvb.2025.167

751

PDF: 224
Venous thromboembolism and mortality in patients with hematological malignancies

Kristen M. Sanfilippo, Tzu-Fei Wang

16-05-2024

https://doi.org/10.4081/btvb.2024.119

731

PDF: 314

1 - 17 of 17 items

Search

Search Results

Distal deep vein thrombosis: is there a way out of this dark forest?

Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective

Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action

Ankle brachial index for the diagnosis of asymptomatic lower extremity peripheral arterial disease

Stroke in women: anticoagulation in a complicated puzzle

The subtle red line between combating and resolving inflammation in the cardiovascular disease, a “silent sniper”

New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

The new era of anticoagulation: factor XI and XII inhibitors

How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Unveiling the “common soil” of cardiovascular disease and cancer

Venous thromboembolism and mortality in patients with hematological malignancies

authors

reviewers

aice

indexing

Keywords